Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients

BackgroundCurrent fertility preservation strategies for young breast cancer patients planning a future motherhood include the association of controlled ovarian stimulation with the aromatase inhibitor letrozole (let-COS) to harvest mature oocytes while maintaining low estradiol levels. Despite this...

Descrición completa

Detalles Bibliográficos

Principais autores:	Françoise Rothé, Matteo Lambertini, Oranite Goldrat, Marion Maetens, Yacine Bareche, Jeremy Blanc, Ghizlane Rouas, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Isabelle Demeestere
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Oncology
Assuntos:	breast cancer fertility preservation letrozole ovarian stimulation circulating tumor DNA
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fonc.2021.686625/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!